The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Rogers Michael W since 2009.
The trader's CIK number is 1244159.
At the time of the last reporting, Rogers Michael W was the Executive Vice Presi of Eyepoint Pharmaceuticals, Inc.. (stock ticker symbol EYPT).
Also see all insider trading activities at Eyepoint Pharmaceuticals, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2009 | IDEV | 0 | $0 | 0 | $0 | 100,443 | $0 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2019 | EYPT | 0 | $0 | 0 | $0 | 6,667 | $0 |
| 2018 | EYPT | 0 | $0 | 0 | $0 | 112,500 | $112,999 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2015 | ACOR | 0 | $0 | 6,664 | $207,574 | 0 | $0 |
| 2014 | ACOR | 0 | $0 | 5,930 | $196,841 | 0 | $0 |
1. Indevus Pharmaceuticals Inc (IDEV)
2. Eyepoint Pharmaceuticals, Inc. (EYPT)
3. Acorda Therapeutics Inc (ACOR)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2009-02-23 | IDEV | Option Ex | 100,443 | .00 | 0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2019-06-21 | EYPT | Option Ex | 6,667 | .00 | 0 |
| 2018-11-15 | EYPT | Option Ex | 100,000 | 1.13 | 112,999 |
| 2018-06-27 | EYPT | Option Ex | 12,500 | .00 | 0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2015-12-01 | ACOR | Sale | 964 | 38.06 | 36,688 |
| 2015-10-07 | ACOR | Sale | 5,700 | 29.98 | 170,886 |
| 2014-12-01 | ACOR | Sale | 230 | 35.58 | 8,183 |
| 2014-10-07 | ACOR | Sale | 5,700 | 33.10 | 188,658 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Rogers Michael W (Executive Vice Presi of Eyepoint Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.